KangaBio
PrivateLast Round
VC Round
Nov 1, 2025
Total Funding Raised
$41M
Company Overview
KangaBio is a biopharmaceutical company that specializes in the discovery and development of novel cancer immunotherapies, including prodrugs of immune agonists and multispecific antibodies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KangaBio Comparables
Compare KangaBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CytomX Therapeutics | 83% | |
| Bonum Therapeutics | 83% | |
| AskGene Pharma | 82% | |
KangaBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 1, 2025 | ||||
| Early Funding | Jun 23, 2023 | ||||
| Angel | Aug 1, 2021 |
KangaBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tianjin TEDA Science and Technology Investment Co., Ltd. | Early Funding |
| Daoyuan Capital | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2021
$11M raised in an angel round.
KangaBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about KangaBio's valuation, stock price, and market status.